You Should Buy Sorrento Before It Reaches New Highs

About: Sorrento Therapeutics, Inc. (SRNE)
by: Tertiary Capital
This article is exclusive for subscribers.

Sorrento Therapeutics is an opportunity for investors that want a growth stock at a reasonable price.

There are many near-term catalysts that can boost the value of the stock.

With great strategic partnerships and a strong pipeline, Sorrento Therapeutics will become a key player in the immuno-oncology (I/O) space.

"Nobody can go back and start a new beginning, but anyone can start today and make a new ending" - Maria Robinson

Sorrento Therapeutics is one of those opportunities you see quite rarely.